SARCOMA CLINICAL TRIAL FUNDED BY STAND UP TO CANCER REDUCES RISK OF RELAPSE BY 43%
June 04, 2024
June 04, 2024
LOS ANGELES, California, June 4 -- The Entertainment Industry Foundation's Stand Up To Cancer issued the following news release on June 3, 2024:
For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a global team of researchers funded by a Stand Up To Cancer(R) (SU2C) grant announced clinical trial results that point to a new immunotherapy treatment option for two of t . . .
For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a global team of researchers funded by a Stand Up To Cancer(R) (SU2C) grant announced clinical trial results that point to a new immunotherapy treatment option for two of t . . .